Additional file 2 of Assessing the effect of interventions for axial spondyloarthritis according to the endorsed ASAS/OMERACT core outcome set: a meta-research study of trials included in Cochrane reviews

Autor: Andreasen, Rikke A., Kristensen, Lars E., Baraliakos, Xenofon, Strand, Vibeke, Mease, Philip J., Wit, Maarten De, Torkell Ellingsen, Hansen, Inger Marie J., Kirkham, Jamie, Wells, George A., Tugwell, Peter, Maxwell, Lara, Boers, Maarten, Egstrup, Kenneth, Christensen, Robin

Additional file 2 Table S1. ASAS/OMERACT core outcome domains. Figure S1. Physical Function. Figure S2. Pain. Figure S3. Spinal mobility. Figure S4. Spinal stiffness. Figure S5. Patient’s global assessment. Figure S6. Peripheral joint count/enthesi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5513f5b2e15813588f34fb1ce711a677

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept - an Observational Study from the Danish Danbio Registry

Autor: Glintborg, Bente, Omerovic, Emina, Danebod, Kamilla, Jensen, Dorte Vendelbo, Nordin, Henrik, Loft, Anne Gitte, Chrysidis, Stavros, Raun, Johnny Lillelund, Hendricks, Oliver, Lindegaard, Hanne, Espesen, Jakob, Jakobsen, Susanne, Hansen, Inger Marie J., Grydehoj, Jolanta, Dalgaard, Emil, Pedersen, Dorte Dalsgaard, Manilo, Natalia, Andersen, Lis Smedegaard, Kristensen, Salome, Linauskas, Asta, Krogh, Niels Steen, Merete Lund Hetland

Publikováno v: Web of Science
Glintborg, B, Omerovic, E, Danebod, K, Jensen, D V, Nordin, H, Loft, A G, Chrysidis, S, Raun, J L, Hendricks, O, Lindegaard, H, Espesen, J, Jakobsen, S, Hansen, I M J, Grydehøj, J, Dalgaard, E, Dalsgaard Pedersen, D, Manilo, N, Andersen, L S, Kristensen, S, Linauskas, A, Krogh, N S & Hetland, M L 2017, ' One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept : – an Observational Study from the Danish Danbio Registry ', The American College of Rheumatology, ACR/ARHP Annual meeting 2017, San Diego, United States, 03/11/2017-08/11/2017 . < http://acrabstracts.org/?post_type=abstracts&s=one-year+clinical+outcomes >
Publons
Glintborg, B, Omerovic, E, Danebod, K, Dorte Vendelbo, J, Nordin, H, Loft, A G, Chrysidis, S, Lillelund Raun, J, Hendricks, O, Lindegaard, H M, Espesen, J, Jakobsen, S, Jensen Hansen, I M, Grydehøj, J, Dalgaard, E B, Dalsgaard Pedersen, D, Manilo, N, Andersen, L S, Kristensen, S, Linauskas, A, Steen Krogh, N & Hetland, M L 2017, ' One-year clinical outcomes in 1623 patients with inflammatory arthritis who switched from originator to biosimilar Etanercept-an observational study from the Danish Danbio Registry ', Arthritis & Rheumatology, vol. 69, no. Suppl. 10, 1550 . https://doi.org/10.1002/art.40321

number 1550

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1693c6a4163e5ecf726b94fd2216909e
https://publons.com/wos-op/publon/21827727/